Engineered DNA Polymerase Nucleotide Discrimination

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current DNA sequencing technologies face challenges in effectively discriminating between cognate and non-cognate nucleotides during the sequencing process, particularly in the absence of cognate nucleotides, leading to reduced accuracy in identifying the next correct nucleotide for DNA replication.

Innovation Solution

Engineered DNA polymerases with specific amino acid substitutions, such as at positions K250, Q281, D355, and D532, are developed to enhance discrimination between cognate and non-cognate nucleotides by altering their affinity for primed template nucleic acids, allowing for improved identification of the next correct nucleotide through reduced binary complex formation and stabilized ternary complex formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If naturally occurring DNA polymerases are used, then DNA replication occurs, but discrimination between cognate and non-cognate nucleotides is insufficient

Engineering Contradiction:
Improvediscrimination accuracyVSAvoidsequencing accuracy
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying the amino acid sequence of DNA polymerase through site-directed mutagenesis. Specific residues (e.g., E290, Q281, D355, Q425, D532) are mutated to alter the enzyme's binding affinity characteristics, enabling reduced binary complex formation while maintaining or enhancing ternary complex stability, thereby improving nucleotide discrimination accuracy

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements local quality by making targeted amino acid substitutions at specific positions within the polymerase active site and nucleotide binding regions. These localized changes (e.g., E290Q, Q281E, D355E) modify the chemical properties of specific residues to enhance discrimination capability without compromising overall enzymatic function

Inventive Principle:
Principle #3Local quality

2Strength

If polymerase affinity for primed template is increased, then binding is enhanced, but binary complex formation increases reducing discrimination capability

Engineering Contradiction:
Improvebinding affinityVSAvoidnucleotide discrimination
Core Design Contradiction:
StrengthVSMeasurement precision

Solution Approach 1:

The patent applies dynamics by creating polymerases with conditional binding characteristics. The engineered polymerases exhibit dynamic behavior where binding affinity is modulated by nucleotide presence: weak binary complex formation in the absence of cognate nucleotides versus stable ternary complex formation when cognate nucleotides are present, enabling discrimination through differential binding dynamics

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent changes the binding parameter profile of the polymerase through amino acid mutations. The modifications alter the energy landscape of complex formation, reducing the stability constant for binary complexes while maintaining or enhancing ternary complex stability, thereby achieving discrimination through parameter optimization

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered DNA polymerases exhibit enhanced discrimination between cognate and non-cognate nucleotides, leading to improved accuracy in identifying the next correct nucleotide, thereby enhancing the sequencing process and reducing errors in DNA replication.

Implementation Method 1

the engineered DNA polymerase has a reduced affinity for the primed template nucleic acid in the absence of a cognate nucleotide, and exhibits a differential affinity for the primed template nucleic acid in the presence and absence of a cognate nucleotide

Methodology Applied
Scientific EffectProtein-nucleic acid binding:

Data Source

PatentUS10597643B2Polymerases engineered to reduce nucleotide-independent DNA binding
Publication Date: 2020.03.24 PACIFIC BIOSCIENCES OF CALIFORNIA INC
  • US10597643B2 patent drawing
  • US10597643B2 patent drawing
  • US10597643B2 patent drawing

AI summary

Provided are engineered DNA polymerases exhibiting modified functionality, and polynucleotides encoding same. Modified features include: (1) reduced catalytic activity in the presence of magnesium ions and/or (2) reduced affinity for primed template nucleic acid molecules in the absence of cognate nucleotide, and an ability to discriminate between cognate and non-cognate nucleotides under low salt conditions. Sequencing By Binding™ procedures employing the engineered polymerases have certain advantages. The engineered polymerases can have other uses as well.